Tikvah Therapeutics Selected for 'Main-Stage' Presentation At the Ninth Annual Southeastern BIO Investor Forum

ATLANTA, Nov. 1, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., an Atlanta, GA-based biopharmaceutical company focused on new treatment options to better manage central nervous system diseases, announced today that it has been chosen as one of only 12 companies selected in the competition for a "main-stage" presentation at the Ninth Annual Southeastern BIO Investor Forum (SEBIO) to be held November 7-8, 2007, in Pinehurst, N.C. Dr. Harold H. Shlevin, president and chief executive officer of Tikvah Therapeutics, Inc., will present a corporate overview on Thursday, November 8, 2007, at 11:15 am EST.

Back to news